×
'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories PDF
$ 0.00
'Caseness' for Depression and Anxiety in a Depressed Outpatient Population: Symptomatic Outcome as a Function of Baseline Diagnostic Categories PDF quantity
$ 0.00
×
Use of Sodium Valproate in Violent and Aggressive Behaviors: A Critical Review PDF
$ 40.00
Use of Sodium Valproate in Violent and Aggressive Behaviors: A Critical Review PDF quantity
$ 40.00
×
When to Refer to Palliative Care PDF
$ 40.00
When to Refer to Palliative Care PDF quantity
$ 40.00
×
Open Trial of Flutamide for Treatment of Obsessive-Compulsive Disorder PDF
$ 40.00
Open Trial of Flutamide for Treatment of Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Nocturnal Wakefulness as a Previously Unrecognized Risk Factor for Suicide PDF
$ 40.00
Nocturnal Wakefulness as a Previously Unrecognized Risk Factor for Suicide PDF quantity
$ 40.00
×
Psilocybin Can Diminish Depression PDF
$ 40.00
Psilocybin Can Diminish Depression PDF quantity
$ 40.00
×
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF
$ 40.00
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF quantity
$ 40.00
×
A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year PDF
$ 40.00
A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
